Nosocomial enterococcal endocarditis: A serious hazard for hospitalized patients with enterococcal bacteraemia

Journal of Internal Medicine

Volumn 252, Issue 6, 2002, Pages 510-515

  Fernández Guerrero, Manuel L ^a   Herrero, L ^a   Bellver, M ^a   Gadea, I ^a   Roblas, R F ^a   De Gorgolas M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Bacteraemia; Enterococcal endocarditis; Nosocomial endocarditis

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENTEROCOCCUS FAECALIS; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; RISK FACTOR; SURGICAL WARD; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0036458945     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01061.x     Document Type: Article

References (34)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
2. Moellering RC. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173-8.
3. Schaberg DG, Culver DH, Gaynes RP. Major trends in the microbioal etiology of nosocomial infections. Am J Med 1991; 91 (Suppl. 3B): 72S-5S.
4. Megran DW. Enterococcal endocarditis. Clin Infect Dis 1992; 15: 63-71.
5. Fernández Guerrero ML, Verdejo C, Azofra J, Górgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: An emerging problem. Clin Infect Dis 1995; 20: 16-23.
6. Facklam R, Sahm DF, Martins Teixeira L. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds Manual of Clinical Microbiology, 7th Edn. Washington, DC: American Society for Microbiology, 1999; 2297-305.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1998. Am J Hosp Infect 1988; 16: 128-40.
8. Durack DT, Lukes AS, Bright D. and the Dukes endocarditis service. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med 1994; 96: 200-9.
9. Wells LD, von Graevenitz A. Clinical significance of enterococci in blood cultures from adults patients. Infection 1980; 8: 147-51.
10. Garrison NR. Fry DE, Berberich S, Polk HC. Enterococcal bacteremia. Clinical implications and determinants of death. Ann Surg 1982; 196: 43-7.
11. Malone DA, Wagner RA, Myers JP, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986; 81: 601-6.
12. Maki DG, Agger WA. Enterococcal bacteremia: Clinical features, the risk of endocarditis and management. Medicine 1988; 67: 248-69.
13. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993; 17: 74-8.
14. Gray J, Marsh PJ, Stewart D, Pedler SJ. Enteroccoccal bacteremia: A prospective study of 125 episodes. J Hosp Infect 1994; 27: 179-86.
15. Paterson JE, Sweeney AH, Simms M et al. An analysis of 110 serious enterococcal infections. Medicine 1995; 74: 191-200.
16. Montecalvo MA, Horowitz H, Gedris C et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-7.
17. Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis 1994; 20: 1126-33.
18. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-33.
19. Handwerger S, Raucher B, Altarac D et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infetc Dis 1993; 16: 750-5.
20. Montecalvo M, Shay DK, Patel P et al. Bloodstream infection with vancomycin-resistant enterococci. Arch Int Med 1996; 156: 1458-62.
21. Mandell GL, Kaye D, Levison ME, Hook EW. Enterococcal endocarditis. An analysis of 38 patients at the New York Hospital-Cornell Medical Center. Arch Int Med 1970; 125: 258-64.
22. Herzstein J, Ryan JL, Mangi RJ, Greco TP, Andriole VT. Optiam therapy for enterococcal endocarditis. Am J Med 1984; 76: 186-91.
23. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Int Med 1984; 100: 816-23.
24. Rice LB, Calderwood SB, Eliopoulos GM, Farber BF, Karchmer AW. Enterococcal endocarditis: A comparison of prosthetic and native valve disease. Clin Infect Dis 1991; 13: 1-7.
25. Vijayvargiya R, Veis JH. Antibiotic-resistant endocarditis in a hemodialysis patient. J Am Soc Nephrol 1996; 7: 536-42.
26. Furlong WB, Rakowski TA. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enteroccocci with VanA/VanB resistance patterns. Clin Infect Dis 1997; 25: 163-4.
27. Matsumura S, Simor A. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: A sinergistic drug combination. Clin Infect Dis 1998; 27: 1554-6.
28. Gray J, Marsh PJ, Stewart D, Pedler SJ. Enterococcal bacteraemia: A prospective study of 125 episodes. J Hosp Infect 1994; 27: 179-86.
29. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome. Clin Infect Dis 1995; 20: 296-301.
30. Fernandez Guerrero ML, Barros C, Rodriguez JL, Soriano F. Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. Eur J Clin Microbiol 1988; 7: 525-7.
31. Tripodi MF, Locatelli A, Adinolfi LE, Andreana A, Utili R. Successful treatment with ampicillin an fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. Eur J Clin Microbiol Infect Dis 1998; 17: 734-6.
32. Lee PY, Das SS. Endocarditis due to high-leevel gentamicin-resistant Enterococcus faecalis. Postgrad Med 1995; 71: 117-9.
33. Soriano F, Zapardiel J, López JC, Fernández Roblas R. In vitro activity of meropenem and other antibiotics against problematic Gram-positive bacteria. Rev Es Quimiotep 1992; 5 (Suppl. 4): 27-9.
34. Dajani AS, Tauber KA, Wilson WR et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997; 277: 1794-801.